BackBio Preventive Medicine Overview

Bio Preventive Medicine Goodwill

Track Bio Preventive Medicine's goodwill ($0) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Goodwill
$0.00

Peer trimmed avg / median

Loading

Bio Preventive Medicine Goodwill History

Loading

Bio Preventive Medicine vs. peers: Goodwill Comparison

Loading

Bio Preventive Medicine Goodwill Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Bio Preventive Medicine (6810.TWO) FAQ

As of the most recent data (June 2026), 6810.TWO shows a goodwill of $0. In the prior-year period, the figure was $0. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, 6810.TWO's goodwill is now $0 (was $0). Pairing that YoY change with peer averages gives a clearer picture of whether Bio Preventive Medicine is outperforming or lagging.

Tracking 6810.TWO's goodwill over time shows whether Bio Preventive Medicine is scaling, shrinking, or reshaping that part of the business. The current reading is $0 In the prior-year period, the figure was $0. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this goodwill page, Stockcircle has Bio Preventive Medicine's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect goodwill (currently $0) with ownership activity and broader fundamentals.

Bio Preventive Medicine's goodwill is $0; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.